Description
Specifications Table
| Product Name | Fmoc-Glu-Odmab |
|---|---|
| Quantity/Pack Size | 5 G |
| Form | Powder |
| Grade | Research Grade |
| Application | Peptide Synthesis |
Product Description
Fmoc-Glu(ODmab) is a specialized amino acid derivative used in solid-phase peptide synthesis. The ODmab (4,4′-dimethoxybenzhydryl) protecting group ensures stability during synthesis while allowing selective deprotection under mild conditions. This high-purity reagent is essential for researchers working on complex peptide sequences, particularly those involving glutamate residues.
Whether you’re a student, educator, or researcher, having reliable reagents like Fmoc-Glu(ODmab) is crucial for accurate results. At eqipped, we provide lab supplies that meet stringent quality standards, ensuring your experiments proceed smoothly.
Need Fmoc-Glu(ODmab) for your next project? Buy online now for fast delivery across India.
The ODmab group is particularly useful in Fmoc-based synthesis because it remains stable during piperidine-mediated Fmoc deprotection but can be selectively removed using trifluoroacetic acid (TFA). This makes it ideal for synthesizing peptides with multiple functional groups.
For best results, store Fmoc-Glu(ODmab) in a cool, dry place away from moisture. Always handle with care in a well-ventilated lab environment.
FAQs
What is Fmoc-Glu(ODmab) used for?
It’s primarily used in peptide synthesis to protect the glutamate side chain during Fmoc-based synthesis.
How is the ODmab group removed?
The ODmab group can be selectively cleaved using trifluoroacetic acid (TFA) under standard conditions.
What is the shelf life of Fmoc-Glu(ODmab)?
When stored properly in a desiccator at -20°C, it remains stable for at least 2 years.
Can I buy Fmoc-Glu(ODmab) in smaller quantities?
Currently, eqipped offers this product in a 5g pack size. For bulk inquiries, contact our support team.
Is this product suitable for therapeutic use?
No, this is a research-grade chemical and not intended for human or animal consumption.
